Back to top

Analyst Sees Operational Inflection and Strengthening Demand Supporting Buy Rating on Sensus Healthcare

Maxim Group analyst Anthony Vendetti has maintained their bullish stance on SRTS stock, giving a Buy rating yesterday. Anthony Vendetti has given h...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Sensus Healthcare, Inc. (SRTS)